United States · Biotechnology startup
United States · Allena Pharmaceuticals
Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.
Funding reportedLast round: Post ipo equity
Follow Allena Pharmaceuticals and see its new rounds in your feed.Start following
What company datasets say Allena Pharmaceuticals raised
Funding, as reported
Reported in all$199Min dollars
Rounds8
Last roundPost ipo equity
Last round dateMay 2022
Investors listed10
SEC Form D$80M sold, 3 filings, last May 2022
Founders and team
From the SEC filings it signed: 2 on the team.
- Louis BrennerExecutive Officer, Directori
- Richard D. KatzExecutive Officeri
On the board, as filediAlexey D. MargolinAllene D. DiazAnn C. MillerGino D. SantiniMark C. Fitzpatrick
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
AbbVieNorth Chicago · founded 2012
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Royalty PharmaNew York · founded 1996
Is this your company?
Add your raise, your deck and your story, and put Allena Pharmaceuticals in front of investors. Or tell us what we have wrong.